Taken together, our results reveal for the first time that the inhibition of ATM phosphorylation efficiently decreases the expressions of MMP-3/MMP-13 and inhibits IL-6 correlated lung cancer metastasis, indicating that the inhibition of ATM phosphorylation is a potential strategy for dealing with inflammation correlating lung cancer metastasis. Here, MMP13 is linked to lung carcinoma.